Manufacturers: Meda pharmaceuticals meda pharmaceuticals inc, Able laboratories inc +13 more
Carisoprodol is a centrally acting muscle relaxant used to relieve the discomfort associated with various musculoskeletal conditions.
Carisoprodol is a centrally acting muscle relaxant used to relieve the discomfort associated with various musculoskeletal conditions.
The mechanism of action of carisoprodol in relieving discomfort associated with acute painful musculoskeletal conditions has not been confirmed. In studies using animal models, the muscle relaxation that is induced by carisoprodol is associated with a change in the interneuronal activity of the spinal cord and of the descending reticular formation, located in the brain. The abuse potential of this drug is attributed to its ability to alter GABAA function. This drug has been shown to modulate a variety of GABAA receptor subunits. GABAA receptor modulation can lead to anxiolysis due to inhibitory effects on neurotransmission.
⑴主要用于治疗急性肌肉痉挛及扭伤、急性骨骼肌疼痛等。仅可短期应用，最多2～3周。 ⑵可用于抗焦虑、肌肉松弛、镇静、失眠等。不推荐长期使用。
2 associated conditions
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
